Your browser doesn't support javascript.
loading
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
Perry, Benjamin I; Vandenberghe, Frederik; Garrido-Torres, Nathalia; Osimo, Emanuele F; Piras, Marianna; Vazquez-Bourgon, Javier; Upthegrove, Rachel; Grosu, Claire; De La Foz, Victor Ortiz-Garcia; Jones, Peter B; Laaboub, Nermine; Ruiz-Veguilla, Miguel; Stochl, Jan; Dubath, Celine; Canal-Rivero, Manuel; Mallikarjun, Pavan; Delacrétaz, Aurélie; Ansermot, Nicolas; Fernandez-Egea, Emilio; Crettol, Severine; Gamma, Franziska; Plessen, Kerstin J; Conus, Philippe; Khandaker, Golam M; Murray, Graham K; Eap, Chin B; Crespo-Facorro, Benedicto.
Affiliation
  • Perry BI; Department of Psychiatry, University of Cambridge, Cambridge, England, United Kingdom.
  • Vandenberghe F; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, England, United Kingdom.
  • Garrido-Torres N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
  • Osimo EF; Virgen del Rocío University Hospital, Network Centre for Biomedical Research in Mental Health (CIBERSAM), Institute of Biomedicine of Seville (IBiS), University of Seville, First-episode Psychosis Research Network of Andalusia (Red PEPSur), Spain.
  • Piras M; Department of Psychiatry, University of Cambridge, Cambridge, England, United Kingdom.
  • Vazquez-Bourgon J; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, England, United Kingdom.
  • Upthegrove R; MRC London Institute of Medical Sciences, Institute of Clinical Sciences, Imperial College, Hammersmith Campus, London, England, United Kingdom.
  • Grosu C; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
  • De La Foz VO; Virgen del Rocío University Hospital, Network Centre for Biomedical Research in Mental Health (CIBERSAM), Institute of Biomedicine of Seville (IBiS), University of Seville, First-episode Psychosis Research Network of Andalusia (Red PEPSur), Spain.
  • Jones PB; Department of Psychiatry, Marques de Valdecilla University Hospital, Institute of Biomedicine Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.
  • Laaboub N; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, England, United Kingdom.
  • Ruiz-Veguilla M; Early Intervention Service, Birmingham Womens and Childrens NHS Foundation Trust.
  • Stochl J; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
  • Dubath C; Department of Psychiatry, Marques de Valdecilla University Hospital, Institute of Biomedicine Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.
  • Canal-Rivero M; Department of Psychiatry, University of Cambridge, Cambridge, England, United Kingdom.
  • Mallikarjun P; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, England, United Kingdom.
  • Delacrétaz A; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
  • Ansermot N; Virgen del Rocío University Hospital, Network Centre for Biomedical Research in Mental Health (CIBERSAM), Institute of Biomedicine of Seville (IBiS), University of Seville, First-episode Psychosis Research Network of Andalusia (Red PEPSur), Spain.
  • Fernandez-Egea E; Department of Psychiatry, University of Cambridge, Cambridge, England, United Kingdom.
  • Crettol S; Department of Kinanthropology, Charles University, Prague, Czech Republic.
  • Gamma F; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
  • Plessen KJ; Virgen del Rocío University Hospital, Network Centre for Biomedical Research in Mental Health (CIBERSAM), Institute of Biomedicine of Seville (IBiS), University of Seville, First-episode Psychosis Research Network of Andalusia (Red PEPSur), Spain.
  • Conus P; Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, England, United Kingdom.
  • Khandaker GM; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
  • Murray GK; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.
  • Eap CB; Department of Psychiatry, University of Cambridge, Cambridge, England, United Kingdom.
  • Crespo-Facorro B; Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, England, United Kingdom.
Lancet Reg Health Eur ; 22: 100493, 2022 Nov.
Article in En | MEDLINE | ID: mdl-36039146
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Lancet Reg Health Eur Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Lancet Reg Health Eur Year: 2022 Type: Article Affiliation country: United kingdom